Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs bioAffinity Technologies, Inc. (BIAF)

Advanced Biomed Inc. and bioAffinity Technologies, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. and bioAffinity Technologies, Inc. are of similar size ($3.3M and $3.1M). bioAffinity Technologies, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −257.3%) and the higher return on invested capital (−33.4% vs −408.7%). Across the 13 metrics below, Advanced Biomed Inc. leads on 13 and bioAffinity Technologies, Inc. on 0.

Valuation

Metric ADVB BIAF Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 0.16 4.24
P/B 0.20 0.25 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.08 23.44
EV/Sales n/m (0.16) 5.18
Earnings yield 300.76% (3,812.50%) (1.50%)
Free cash flow yield (185.35%) (1,223.67%) 0.00%

Profitability

Metric ADVB BIAF Diagnostics & Research median
Gross margin — 34.61% 48.32%
Operating margin 0.00% (209.82%) (5.68%)
Net margin 0.00% (257.33%) (4.10%)
Free cash flow margin 0.00% (195.90%) 0.00%
Return on equity 84.77% (1,860.15%) 0.00%
Return on assets 36.47% (245.51%) (6.05%)
Return on invested capital (33.43%) (408.67%) 0.00%

Growth

Metric ADVB BIAF Diagnostics & Research median
Revenue growth (TTM) — (23.18%) 8.99%
EPS growth (last fiscal year) 266.56% 61.55% 20.36%
Revenue growth, 5-year CAGR — — 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB BIAF Diagnostics & Research median
Debt to equity 0.00 0.15 0.01
Current ratio 9.33 1.44 2.27
Net debt to EBITDA 0.06 0.57 0.68

Dividend

Metric ADVB BIAF Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB BIAF Diagnostics & Research median
Market cap 3.14m 3.34m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack